22 completed, 5 recruiting, 4 terminated, 4 unknown. 14 Phase 2, 10 Not applicable, 6 Phase 1, 3 Early Phase 1, 3 Phase 3.
Follow Neuroendocrine Tumor: new trials by email Literature Review of Neuroendocrine Tumor trials Research Report on Neuroendocrine Tumor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Investigational Scan ([68Ga] Ga-FAPI-04 PET/CT) for the Imaging of Patients With High-Grade Neuroendocrine Cancer Computed Tomography, Gallium Ga 68-DOTA-FAPI-04, Positron Emission Tomography - Neuroendocrine Tumor | Early Phase 1 | Recruiting | University of Michigan Rogel Cancer Center | 30 | 2025-09-16 | 2026-07-31 |
| Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases Biospecimen Collection, Exercise Intervention, Magnetic Resonance Imaging - Malignant Brain Neoplasm, Malignant Solid Neoplasm | Not applicable | Recruiting | Mayo Clinic | 147 | 2025-02-05 | 2026-06-10 |
| Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes PICO G2 4k - Cancer Pain, Visceral Pain | Not applicable | Recruiting | Cedars-Sinai Medical Center | 360 | 2021-10-05 | 2026-11-12 |
| Intra-arterial Hepatic (IAH) Infusion of Radiolabelled Somatostatin Analogs in GEP-NET Patients With Dominant Liver Metastases Positron emission tomography computed tomography (PET/CT) with Intra-hepatic (IAH) injection, Positron emission tomography computed tomography (PET/CT) with Intravenous (IV) injection, LUTATHERA® by intra-arterial hepatic (IAH) injection - Neuroendocrine Tumor, Liver Metastases | Phase 2 | Recruiting | University Hospital, Bordeaux | 23 | 2021-09-24 | 2025-07-23 |
| 18F-MFBG PET/CT in the Evaluation of Neural Crest Tumor 18F-MFBG, 68Ga-Dotatate - Neuroendocrine Tumor, Neuroblastoma | Early Phase 1 | Recruiting | Peking Union Medical College Hospital | 150 | 2021-09-01 | 2024-03-01 |
| Retrospective Analysis of Patients Re-treated With Lutetium-177 DOTATATE (Lutathera®) Lutetium-177 DOTATATE - Neuroendocrine Tumor | Completed | Novartis Pharmaceuticals | 31 | 2021-09-01 | 2023-04-18 | |
| Oral Protein Supplements for Nutritional and Quality of Life Improvement After Pancreatic Resection in Elderly Patients oral protein supplements, placebo - Pancreatic Cancer, Cholangiocarcinoma | Not applicable | Completed | Yonsei University | 60 | 2021-01-07 | 2024-08-26 |
| Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study Cabozantinib 40 mg - Neuroendocrine Tumor, Anaplastic Thyroid Cancer | Phase 2 | Completed | Grupo Espanol de Tumores Neuroendocrinos | 93 | 2020-10-07 | 2025-06-19 |
| Enterade in Carcinoid/Non-Carcinoid Syndrome Neuroendocrine Tumor Patients With Quality of Life Limiting Bowel Frequency Enterade®, Functional Assessment of Chronic Illness Therapy for Patients with Diarrhea (version 4.0) - Neuroendocrine Tumor, Carcinoid Syndrome | Not applicable | Terminated | Vanderbilt-Ingram Cancer Center | 11 | 2019-11-04 | 2021-05-21 |
| Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors Biospecimen Collection, Cabozantinib S-malate, Computed Tomography - Functioning Pancreatic Neuroendocrine Tumor, Intermediate Grade Lung Neuroendocrine Neoplasm | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 298 | 2018-10-26 | 2026-11-13 |
| Phase 1 Study of AlphaMedix™ in Adult Subjects With SSTR (+) NET AlphaMedix - Neuroendocrine Tumor | Phase 1 | Terminated | Orano Med LLC | 33 | 2018-02-05 | 2025-06-10 |
| A Study of XmAb®18087 in Subjects With NET and GIST XmAb18087 - Neuroendocrine Tumor, Gastrointestinal Neoplasm | Phase 1 | Completed | Xencor, Inc. | 62 | 2018-01-22 | 2022-05-10 |
| Yttrium-90 DOTA-TOC Intra-arterial (IA) Peptide Receptor Radionuclide Therapy (PRRT) for Neuroendocrine Tumor 90Y-DOTA-TOC, 68Ga-DOTA-TOC - Neuroendocrine Tumor | Early Phase 1 | Completed | Thomas Hope | 10 | 2017-07-01 | 2020-07-07 |
| Surgical Intervention and the NETest Surgery - Neuroendocrine Tumor, Gastroenteropancreatic | Not applicable | Completed | Wren Laboratories LLC | 30 | 2017-05-15 | 2026-08-21 |
| DIVIT Study Diet and Vitamin Supplementation in Patients With a Neuroendocrine Tumor Vitamin supplement;, Diet advice - Neuroendocrine Tumor | Not applicable | Completed | University Medical Center Groningen | 53 | 2016-12-15 | 2024-05-06 |
| Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) pembrolizumab - Advanced Cancer, Anal Carcinoma | Phase 2 | Active not recruiting | Merck Sharp & Dohme LLC | 1609 | 2015-12-18 | 2025-09-22 |
| Optimal Feeding for NET Patients Dietary intervention, Standard treatment - Neuroendocrine Tumor | Not applicable | Completed | University Medical Center Groningen | 15 | 2015-05-01 | 2024-05-06 |
| Web-based Tailored Information and Support for Patients With a Neuroendocrine Tumor Web-based tailored information and support system, Standard care - Neuroendocrine Tumor | Not applicable | Completed | University Medical Center Groningen | 91 | 2015-05-01 | 2024-05-06 |
| RegisterNET - A Registry for Neuroendocrine Tumors in the USA and Worldwide NETest - Neuroendocrine Tumor, Carcinoid | Enrolling by invitation | Wren Laboratories LLC | 400 | 2015-02-01 | 2025-11-13 | |
| GA-68 DOTA-TOC of Somatostatin Positive Malignancies Computed Tomography (CT), Gallium Ga 68-Edotreotide, Magnetic Resonance Imaging (MRI) - Neuroendocrine Tumor, Paraganglioma | Phase 1 / Phase 2 | Terminated | University of California, San Francisco | 300 | 2014-06-23 | 2019-11-12 |
Showing 20 of 40. Sign in to see all of them.
Neuroendocrine Tumors (40) · Carcinoid Tumor (9) · Adenoma, Islet Cell (7) · Neoplasms (4) · Neuroblastoma (4) · Carcinoma, Islet Cell (3) · Carcinoma, Neuroendocrine (3) · Pancreatic Neoplasms (3) · Paraganglioma (3) · Somatostatinoma (3) · Anus Neoplasms (2) · Bile Duct Neoplasms (2) · Biliary Tract Neoplasms (2) · Cholangiocarcinoma (2) · Gastrinoma (2)
Neoplasms by Histologic Type (40) · Neoplasms, Germ Cell and Embryonal (40) · Neoplasms, Nerve Tissue (40) · Neuroectodermal Tumors (40) · Neoplasms (36) · Neoplasms, Glandular and Epithelial (18) · Neoplasms by Site (15) · Adenocarcinoma (14) · Carcinoma (14) · Digestive System Diseases (14) · Digestive System Neoplasms (14) · Endocrine Gland Neoplasms (13) · Endocrine System Diseases (13) · Pancreatic Diseases (12) · Adenoma (9)
Magnetic Resonance Spectroscopy (6) · gallium Ga 68 dotatate (4) · Everolimus (3) · Bevacizumab (2) · Sorafenib (2) · Specimen Handling (2) · cabozantinib (2) · 3-fluorobenzylguanidine (1) · 68Ga-FAPI (1) · 90Y-octreotide, DOTA-Tyr(3)- (1) · Acetates (1) · Diet Therapy (1) · Disulfides (1) · Fluorouracil (1) · Ga(III)-DOTATOC (1)
University Medical Center Groningen (5) · Dana-Farber Cancer Institute (4) · National Cancer Institute (NCI) (3) · Novartis Pharmaceuticals (2) · University of California, San Francisco (2) · Wren Laboratories LLC (2) · Cedars-Sinai Medical Center (1) · Fox Chase Cancer Center (1) · Grupo Espanol de Tumores Neuroendocrinos (1) · H. Lee Moffitt Cancer Center and Research Institute (1) · Hadassah Medical Organization (1) · Mayo Clinic (1) · Merck Sharp & Dohme LLC (1) · Nuclear Medicine Consultants, Inc. (1) · Ochsner Health System (1)
United States (26) · Netherlands (6) · France (2) · Italy (2) · South Korea (2) · Spain (2) · Argentina (1) · Australia (1) · Belgium (1) · Canada (1) · China (1) · Denmark (1) · Germany (1) · Israel (1) · Sweden (1)
A. M.E. Walenkamp, MD, PhD (2) · Annemiek ME Walenkamp, MD, PhD (1) · Benjamin Viglianti (1) · Brennan Spiegel, MD, MSHS (1) · Emily K. Bergsland, MD (1) · Emily R. Winslow, MD (1) · Fang Li (1) · James C Yao (1) · Jaume Capdevila, M.D, Ph.D (1) · Jennifer A Chan (1) · Jennifer Ang Chan, MD, MPH (1)
PMID 22736724, PMID 23475104, PMID 23989950, PMID 26032155, PMID 26370353, PMID 26456125, PMID 28185086, PMID 28384065, PMID 30158287, PMID 30819238, PMID 30943124, PMID 31682550, PMID 31980466, PMID 32359091, PMID 32392558, PMID 32919526, PMID 33152282, PMID 33836153, PMID 34990208, PMID 35114169, PMID 35361487, PMID 35588692, PMID 35680043, PMID 35777186, PMID 35835611, PMID 36748723, PMID 37160439, PMID 39282913, PMID 39945192, PMID 39979665, PMID 40121391, PMID 40717185, PMID 41524552, PMID 41920388
2015 (1), 2019 (1), N01CM62205 (1), P30CA006927 (1), P30CA086862 (1), R01CA167632 (1), R01CA252211 (1), U10CA032102 (1), U10CA180821 (1), U10CA180888 (1)